Vincent Rajkumar: Treatment of newly diagnosed myeloma in one slide

Vincent Rajkumar shared on X:

“Treatment of newly diagnosed myeloma in one slide. Based on 4 recent phase IIIs practice has changed and has become easier.”

Yelak Biru, President and CEO at International Myeloma Foundation, replied to the post, adding:

“I just heard about a myeloma patient who is 21 years post-ASCT with no additional maintenance or relapse. Way on the right side of the bell curve. If eligible, I guess don’t throw ASCT out the window yet!”

Source: Vincent Rajkumar/X and Yelak Biru/X

Vincent Rajkumar is a Professor of Medicine at the Mayo Clinic in Rochester, Minnesota, and Chair for the Mayo Clinic Myeloma, Amyloidosis, and Dysproteinemia Group. He also chairs the Board of directors of  The International Myeloma Foundation and the Eastern Cooperative Oncology Group (ECOG) Myeloma Committee.

His extensive contributions include over 230 peer-reviewed publications, predominantly focusing on multiple myeloma and related plasma cell disorders. Furthermore, Dr. Rajkumar is a Section Editor for multiple myeloma and related disorders for Leukemia and an Associate Editor for the Mayo Clinic Proceedings.